QYResearch Reviewed: In 2016, global revenue of Real-Time PCR machines is nearly 621 M USD
QYResearch 已封禁 最后由 编辑
Real-Time PCR Machines is a machine that amplifies and detects DNA. Scientists in all areas of life science — basic research, biotechnology, medicine, forensics, diagnostics, and more — utilize these machines in a wide range of applications. Real-Time PCR machines can be used for both qualitative and quantitative analysis.
Real-Time PCR allows the precise quantification of these nucleic acids with greater reproducibility. Advantages of Real-Time PCR include the ease of quantification, greater sensitivity, reproducibility and precision, rapid analysis, better control of quality in the process and a lower risk of contamination.
In the last several years, global market of Real-Time PCR machines developed rapidly, with an average growth rate of 7%. In 2016, global revenue of Real-Time PCR machines is nearly 621 M USD; the actual production is about 29.4 K units.
The global average price of Real-Time PCR machines is in the decreasing trend, from 22.1 K USD/Unit in 2012 to 21.1 K USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Real-Time PCR machines includes LED, Halogen Lamp and others, and the proportion of LED in 2016 is about 61%, and the proportion is in decreasing trend from 2012 to 2016.
Real-Time PCR machines are widely used in universities, hospitals and other field. The most proportion of Real-Time PCR machines is used by universities, and the revenue in 2016 is 434 M USD.
North America region is the largest supplier of Real-Time PCR machines, with a production market share nearly 45% in 2016. Europe is the second largest supplier of Real-Time PCR machines, enjoying production market share nearly 34% in 2015.
North America is the largest consumption place, with a consumption market share nearly 40% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 29%.
Market competition is intense. Thermo Fisher, Roche, QIAGEN, Bio-rad, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
More Detail: http://www.qyresearchglobal.com/goods-675064.html